SEC Form 4 · accession 0001514346-15-000002
ARENA PHARMACEUTICALS INC · ARNA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jennifer Kathleen Bielasz
Officer — VP, Accounting & Controller
Period of report
Dec 15, 2015
Accepted (ET)
Dec 17, 2015 · 7:45 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001080709
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $1.79 | Dec 15, 2015 | A | 90,000 | A | — | Dec 15, 2022 | Common Stock | 90,000 | 90,000 | D |
Explanation of responses
- F1The options vest in four equal annual installments beginning on December 15, 2016, and are exercisable once vested.